Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine. | NobleBlocks
Public
Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine.
N
Shared by NobleBlocks on Jan 13, 2011 • 12:00 AM UTC
